Matthew C. Hill - 13 Aug 2024 Form 4/A - Amendment Insider Report for Apyx Medical Corp (APYX)

Role: Chief Financial Officer
Signature: /s/ Matthew C. Hill
Issuer symbol: APYX
Transactions as of: 13 Aug 2024
Net transactions value: +$6,780
Form type: 4/A - Amendment
Filing time: 03 Mar 2025, 16:05:12 UTC
Date Of Original Report: 13 Aug 2024
Previous filing: 11 Jan 2024
Next filing: 17 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APYX	Common Stock	Purchase	$6,780	+6,000	+240%	$1.13	8,500	13 Aug 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the addition of 664 shares that were inadvertently omitted from the Reporting Person's original Form 4.
F2	This transaction was executed in multiple trades at prices ranging from $1.12 to $1.13. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Content

Reflects the addition of 664 shares that were inadvertently omitted from the Reporting Person's original Form 4.

This transaction was executed in multiple trades at prices ranging from $1.12 to $1.13. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.